SCM
IMUX icon

Silverarc Capital Management’s Immunic IMUX Stock Holding History

Silverarc Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,066
Closed -$491K – 91
2022
Q4 		$491K Buy
+35,066
New +$956K 0.14% 78
2022
Q2 		– Sell
-6,848
Closed -$774K – 77
2022
Q1 		$774K Buy
+6,848
New +$793K 0.32% 55

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Silverarc Capital Management's IMUX Position: Q1 2023 in Review

Silverarc Capital Management sold out of Immunic (IMUX) in Q1 2023, closing a stake of 35,066 shares — an estimated $491K sold.

Silverarc Capital Management first reported a position in IMUX in Q1 2022 and held it in 2 quarters. The position peaked at $774K in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q1 2023.

  • Silverarc Capital Management reported no remaining Immunic position as of Q1 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 35,066 Immunic shares in Q1 2023, an estimated $491K.
  • Silverarc Capital Management first reported a position in Immunic in Q1 2022 and held it in 2 quarters.
  • Silverarc Capital Management's Immunic position peaked at $774K in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q1 2023.

Based on Silverarc Capital Management's 13F filing for Q1 2023, filed 15 May 2023.